Skip to main content

Month: January 2025

Topicus.com Inc. Reaches Agreement to acquire Cipal Schaubroeck in Belgium

TORONTO, Jan. 14, 2025 (GLOBE NEWSWIRE) — Constellation Software Inc. (TSX: CSU) and Topicus.com Inc. (TSXV: TOI) today announced that Topicus’ subsidiary Total Specific Solutions (TSS) B.V. (“TSS”) has entered into a binding agreement with CIPAL NV and Mr. Schaubroeck in respect of the sale and transfer of all issued and outstanding shares in the capital of Cipal Schaubroeck NV to TSS. Cipal Schaubroeck NV (“CP”) is a Belgium-based vertical market software provider active in the local government vertical with annual gross revenues of approximately €110M in 2024. CP employs over 590 employees (561 full time equivalents). The transaction is currently expected to close in Q1 2025, subject to the satisfaction of certain standard closing conditions including clearance from the Belgian Interfederal Screening Commission. About Topicus.com Topicus.com...

Continue reading

Pasithea Therapeutics Announces Opening of European Clinical Trial Sites and Completes Initial Dosing of Cohort 4

— Interim data from Cohort 4 expected Q1 2025 — MIAMI, Jan. 14, 2025 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK inhibitor, for the treatment of neurofibromatosis type 1 (NF1) and other cancer indications, today announced it has opened three clinical trial sites in Eastern Europe. These sites in Romania and Bulgaria are actively recruiting patients along with the four open sites in the United States, for Pasithea’s PAS-004 Phase 1 trial. In Eastern Europe, Pasithea is working with Arensia Exploratory Medicine, Institute of Oncology Bucharest, Arensia Exploratory Medicine, Institute of Oncology Cluj-Napoca, and Arensia Exploratory Medicine, Multiprofile Hospital for Active Treatment...

Continue reading

Enstar Legacy Syndicate 2008 Agrees $196m LPT Deal with Atrium Syndicate 609

HAMILTON, Bermuda, Jan. 14, 2025 (GLOBE NEWSWIRE) — Enstar Group Limited (“Enstar”) (Nasdaq: ESGR) announced today its Lloyd’s syndicate (“Syndicate 2008”), managed by Enstar Managing Agency Limited, has agreed a ground-up loss portfolio transfer (“LPT”) with Atrium Syndicate 609, managed by Atrium Underwriters Limited. The transaction involves Syndicate 609’s discontinued portfolios, comprising Marine Treaty Reinsurance, Property Treaty Reinsurance and US Contractors General Liability. Under the terms of the LPT, Atrium Syndicate 609 will cede net loss reserves of approximately $196 million, based on Atrium’s carried reserves as at Q3 2024, to Enstar’s Syndicate 2008. The reinsurance relates to business underwritten in the 2023 and prior years of account, with all claims handling transferring to Syndicate 2008. The transaction...

Continue reading

Inmar Intelligence Sharpens Focus on Healthcare and Martech with Strategic Divestiture

WINSTON-SALEM, NC, Jan. 14, 2025 (GLOBE NEWSWIRE) — Inmar Intelligence, a leader in technology-driven solutions, announced the divestiture of its Supply Chain Solutions division to DHL Supply Chain. This strategic move allows Inmar to prioritize its Healthcare and Martech businesses by continuing to drive innovation and deliver enhanced value to customers and consumers in these rapidly evolving markets, as well as offering an opportunity to build upon Inmar’s long-standing leadership of returns solutions through DHL. Inmar retains and continues investing in its pharmaceutical reverse distribution business, including Rx Returns and Rx Recalls.  “The divestiture sets the stage for an even deeper focus at Inmar Intelligence. That focus will be centered on executing an even more aggressive innovation pipeline on behalf of the Healthcare...

Continue reading

Emergent BioSolutions Gains Exclusive Commercial Rights to KLOXXADO® (naloxone HCI) Nasal Spray from Hikma Pharmaceuticals

Alongside over-the-counter NARCAN® Nasal Spray 4 mg, prescription KLOXXADO® (naloxone HCl) Nasal Spray 8 mg will expand Emergent’s ability to distribute multiple life-saving opioid overdose emergency treatments to patients, customers and communities in need Focus remains on increasing access, raising awareness and ensuring strong supply to meet the ongoing demand of naloxone nasal sprayGAITHERSBURG, Md., Jan. 14, 2025 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has entered into an agreement to obtain exclusive commercial rights in the U.S. and Canada to Hikma Pharmaceuticals’ KLOXXADO® (naloxone HCl) Nasal Spray, an 8 mg naloxone agent that is approved for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression.1...

Continue reading

Sotera Health Chairman and CEO Presents at 43rd Annual J.P. Morgan Healthcare Conference

CLEVELAND, Jan. 14, 2025 (GLOBE NEWSWIRE) — Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, is presenting today at the 43rd Annual J.P. Morgan Healthcare Conference. During the presentation, Chairman and CEO Michael B. Petras, Jr. will be providing an update on Sotera Health’s business. “I am pleased to announce that Sotera Health delivered another year of top-line growth in 2024,” said Mr. Petras. “We expect full-year revenues will be approximately $1.1 billion, representing growth of nearly 5% versus 2023 and more than 5% growth on a constant currency basis. The growth we experienced in 2024 is a testament to the resiliency of our business model, which allows...

Continue reading

FirstService to Announce Fourth Quarter and Annual Results for 2024 on February 5, 2025

TORONTO, Jan. 14, 2025 (GLOBE NEWSWIRE) — FirstService Corporation (TSX and NASDAQ: FSV) (“FirstService”) announced today that it will release its financial results for the fourth quarter ended December 31, 2024 by press release on Wednesday, February 5, 2025 at approximately 7:30 am ET. The conference call to review these financial results will take place at 11:00 am ET on Wednesday, February 5, 2025, and will be hosted by D. Scott Patterson, CEO, and Jeremy Rakusin, CFO. This call is being webcast live at the Company’s website at www.firstservice.com. Participants may register for the call here https://register.vevent.com/register/BIc0caa93df85548909c3b68b8c526df66 to receive the dial-in number and their unique PIN. To join the webcast in listen only mode, use this link: https://edge.media-server.com/mmc/p/zvtxjnkg. It is recommended...

Continue reading

Angus Gold Commences 2025 Drilling Program on the Golden Sky Project, Wawa

TORONTO, Jan. 14, 2025 (GLOBE NEWSWIRE) — Angus Gold Inc. (TSX-V: GUS | OTC: ANGVF) (“Angus” or the “Company”) is pleased to announce it has commenced its 2025 drilling program on its 100%-owned Golden Sky Project located in Wawa, Ontario.   The 2025 drill program will continue to expand and delineate gold mineralization at the Company’s Dorset and BIF Zones. The majority of the winter drilling will be focused on the Dorset Gold Zone with infill drilling planned along the historical resource area in addition to step-out drilling planned on the eastern extension and the western extension, where Angus has successfully intersected a new zone of high-grade gold, including 7.0 g/t Au over 12.4 metres in Hole GS-24-136 (see News Release of May 7, 2024). Highlights:15,000 metres of drilling planned for the Golden Sky Project in 2025. Drill...

Continue reading

Global Crossing Airlines and United Airlines Collaborate Through Airblox for Seamless Cargo Transportation Between San Juan and Chicago

MIAMI, Jan. 14, 2025 (GLOBE NEWSWIRE) — Global Crossing Airlines Group, Inc. (Cboe CA: JET, Cboe CA: JET.B, OTCQB: JETMF) (the “Company” or “GlobalX”), the Nation’s fastest growing charter airline, today announced that it has entered into a digital interline agreement with United Airlines through Airblox’s innovative electronic Block Space Agreement (“eBSA”), enabling efficient cargo transport between San Juan (SJU) and Chicago (ORD). GlobalX operates round-trip cargo charter flights between San Juan (SJU) and Chicago (ORD) three times per week. These flights, scheduled for Mondays, Wednesdays, and Fridays, utilize GlobalX’s advanced Airbus A321F freighter, offering an impressive 25 tons of cargo capacity in each direction. This service is exclusively accessible via the Airblox platform, reflecting its pivotal role...

Continue reading

Amerigo Reports 2024 Operational Results & Provides 2025 Guidance

2024 Copper Production of 64.6 million pounds, Outperforming Guidance 2024 Cash Cost1 $1.89 per pound, Outperforming Guidance 2025 Guidance Sees Amerigo Debt-Free by Year-end VANCOUVER, British Columbia, Jan. 14, 2025 (GLOBE NEWSWIRE) — Amerigo Resources Ltd. (TSX: ARG; OTCQX: ARREF) (“Amerigo” or the “Company”) is pleased to announce 2024 production results from Minera Valle Central (“MVC”), the Company’s 100% owned operation located near Rancagua, Chile. Dollar amounts in this news release are in U.S. dollars (“USD”) unless indicated otherwise. Amerigo is pleased to report very strong 2024 production and cash cost1 results at MVC, significantly beating production and cost guidance. Copper production was 64.6 million pounds, with a Company record of 65.0 million pounds of copper deliveries. Molybdenum production and sales were...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.